Seminar Schedules
SCHEDULE Semester 1, 2008
All seminars are from 12:00 Thursdays in Rm F7B322 (unless otherwise stated); all welcome.
This semester we highlight local talent in the Sydney region relevant to the depth of research in the new Department of Chemistry & Biomolecular Sciences as well as some distinguished overseas visitors.
Time & Date |
Speaker |
Seminar title |
6 March |
CBMS Honours students |
CBMS Honours seminars |
13 March |
Dr Tom Roberts
CBMS, Macquarie University |
"DNA Damage Responses in Plants and their Regulation by Serpins" |
27 March |
Dr Nikki Verrills
School of Biomedical Sciences, University of Newcastle & Hunter Medical Research Institute (HMRI)
|
"Protein phosphatases in cancer: the crucial role of PP2A and its potential as a novel anticancer target" |
3 Apr |
Prof. Ed Nice
Protein Biosensing Department, Ludwig Institute for Cancer Research, Melbourne
|
"Biosensors, biomarkers, micropurification and cancer" |
10 Apr |
Prof. Mark Willcox
School of Optometry and Vision Science, UNSW
|
"Tear Film in Health and Disease" |
17 Apr |
Dr. Heung-Chin Cheng
Department of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne
|
"CSK-homologous kinase (CHK) an endogenous inhibitor targeting all active conformations of the Src-family protein tyrosine kinases " |
8 May |
Prof. Marc Wilkins
School of Biotechnology and Biomolecular Sciences
University of New South Wales
|
"The Dynamics of the Interactome " |
22 May |
Daniela Stock
Department Structural and Computational Biology Division
Affiliation Victor Chang Cardiac Research Institute
|
"Structure, function and regulation of proton translocating ATPases" |
5 June |
Dr. Robert Moritz
Director, Australian Proteomics Computational Facility Ludwig Institute For Cancer Research, Melbourne Victoria
|
"The Australian Proteomics Computational Facility - Utilising a large computing resource for your Proteomics research " |
12 June |
Dr Xavier Franck
CNRS, University Rouen, France
|
"Synthesis of natural products and analogues: From cytotoxicity to fluorescence " |
19 June |
Peter J. Hudson PhD, FTSE.
CSIRO Fellow and HUPO-Human Antibody Co-Chair. CEO (and Co-founder) of AviPep Pty Ltd and Co-founder of EvoGenix (now Arana Ltd).
|
"Engineered antibodies are high-value Biopharmaceutical and Diagnostic reagents and also validate novel proteomic biomarkers" |
26 June |
Associate Professor Maria Kavallaris
Pharmacoproteomics Program, Children’s Cancer Institute Australia
|
"Cytoskeletal Proteins and Drug Resistance in Cancer" |
Please e-mail Nicki Packer (nicki.packer@mq.edu.au)
for the 2008 seminar schedule or to make enquiries about presenting a seminar.
Directions for getting to the Department can be found here.
